Vida Ventures is founded and led by physician-scientists who use a science-led, discipline-driven strategy to translate breakthrough biology into drugs, with co-founder Arjun Goyal emphasizing a patient-centric lens that asks what would change standard of care for specific diseases. The fund is known for being deeply involved in company creation and early strategic design—helping assemble founding teams, shape development plans, and design pivotal trials—rather than only writing checks into already-formed biotechs.